Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution

被引:25
作者
Kami, M [1 ]
Mori, S [1 ]
Tanikawa, S [1 ]
Akiyama, H [1 ]
Onozawa, Y [1 ]
Tanaka, T [1 ]
Okamoto, R [1 ]
Maeda, Y [1 ]
Sasaki, T [1 ]
Haku, H [1 ]
Matsuura, Y [1 ]
Hiruma, K [1 ]
Sakamaki, H [1 ]
机构
[1] TOKYO METROPOLITAN KOMAGOME HOSP,BONE MARROW TRANSPLANTAT TEAM,BUNKYO KU,TOKYO 113,JAPAN
关键词
BMT; VOD; risk factors; pseudocholinesterase;
D O I
10.1038/sj.bmt.1700895
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
One hundred and thirty-seven consecutive patients who received bone marrow or peripheral blood stem cell transplantation were studied retrospectively to identify the risk factors for hepatic veno-occlusive disease (VOD). Of the 137 recipients, twenty (14.6%) patients were diagnosed with VOD using the McDonald's criteria, In these 20 patients with VOD, we analyzed various clinical parameters, including age, sex, HLA status, conditioning regimen, irradiation, immunosuppressive agents, mode of transplantation, history of hepatic dysfunction, pre-transplant hepatic and renal function, infectious episodes, antibiotics use, and serum viral titers. A history of hepatic dysfunction and low levels of pseudocholinesterase before transplantation were found to be statistically significant (P = 0.04 and 0.04). Low levels of pseudocholinesterase were significant by multivariate analysis using the logistic regression model (P = 0.02), These results suggest that pseudocholinesterase levels before transplant are important markers of VOD in patients receiving BMT.
引用
收藏
页码:397 / 402
页数:6
相关论文
共 17 条
[1]  
BEARMAN SI, 1990, BONE MARROW TRANSPL, V5, P407
[2]  
BLOSTEIN MD, 1992, BONE MARROW TRANSPL, V10, P439
[3]  
CATANI L, 1993, BONE MARROW TRANSPL, V12, P253
[4]   VENOCCLUSIVE DISEASE OF THE LIVER AFTER CHEMORADIOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION [J].
DULLEY, FL ;
KANFER, EJ ;
APPELBAUM, FR ;
AMOS, D ;
HILL, RS ;
BUCKNER, CD ;
SHULMAN, HM ;
MCDONALD, GB ;
THOMAS, ED .
TRANSPLANTATION, 1987, 43 (06) :870-873
[5]  
ESSELL JH, 1992, BONE MARROW TRANSPL, V10, P367
[6]  
GENTZ HD, 1978, MED KLIN, V73, P1422
[7]   SERUM PROCOLLAGEN TYPE-III IS AN EARLY AND SENSITIVE MARKER FOR VENOOCCLUSIVE DISEASE OF THE LIVER IN CHILDREN UNDERGOING BONE-MARROW TRANSPLANTATION [J].
HEIKINHEIMO, M ;
HALILA, R ;
FASTH, A .
BLOOD, 1994, 83 (10) :3036-3040
[8]   VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE-MARROW TRANSPLANTATION [J].
JONES, RJ ;
LEE, KSK ;
BESCHORNER, WE ;
VOGEL, VG ;
GROCHOW, LB ;
BRAINE, HG ;
VOGELSANG, GB ;
SENSENBRENNER, LL ;
SANTOS, GW ;
SARAL, R .
TRANSPLANTATION, 1987, 44 (06) :778-783
[9]  
Lemberg A, 1981, Acta Gastroenterol Latinoam, V11, P125
[10]  
MARSAVILA L, 1991, EUR J HAEMATOL, V47, P346